Retentate chromatography and protein chip arrays with applications in biology
View Patent ↗This invention provides methods of retentate chromatography for resolving analytes in a sample. The methods involve adsorbing the analytes to a substrate under a plurality of different selectivity conditions, and detecting the analytes retained on the substrate by desorption spectrometry. The methods are useful in biology and medicine, including clinical diagnostics and drug discovery.
1. A kit comprising:
(1) at least one laser desorption/ionization mass spectrometry probe substrate comprising a plurality of different adsorbents, each adsorbent attached to the at least one substrate at different addressable locations;
(2) at least one container comprising at least one eluant; and
(3) instructions for detecting a plurality of polypeptides that are diagnostic markers by contacting the adsorbents with a sample comprising the polypeptides, capturing the polypeptides on the different adsorbents, washing the adsorbents with the at least one eluant, and detecting the captured polypeptides by laser desorption/ionization mass spectrometry.
2. The kit of claim 1 wherein each of the plurality of adsorbents is attached to the same substrate.
3. The kit of claim 1 wherein each of the plurality of adsorbents is attached to different substrates.
4. The kit of claim 1 wherein the adsorbents are selected from the group consisting of hydrophobic interaction adsorbents, hydrophilic interaction adsorbents, anionic interaction adsorbents, cationic interaction adsorbents and coordinate covalent interaction adsorbents.
5. The kit of claim 4 wherein the adsorbents have different bases of attraction wherein the bases of attraction are selected from the group consisting of hydrophobic interaction, hydrophilic interaction, anionic interaction, cationic interaction and coordinate covalent interaction.
6. The kit of claim 1 wherein each of the plurality of adsorbents is a biospecific adsorbent that specifically binds a diagnostic marker.
7. The kit of claim 6 wherein the biospecific adsorbent comprises an antibody.
8. The kit of claim 1 wherein the disease is cancer.
9. The kit of claim 1 wherein the disease is selected from the group consisting of heart disease, autoimmune disease, viral infection, Alzheimer's disease and diabetes.
10. The kit of claim 1 wherein the sample is selected from the group consisting of tissue, blood, urine, stool, lymph, cerebrospinal fluid and interarticular fluid.